Learn More
Medchemexpress LLC KW-8232 | 217813-15-5 | 98.1% | 705.26 | C37H41ClN4O6S | 5 MG

Supplier: Medchemexpress LLC HY100304A5MG
KW-8232 is an orally active anti-osteoporotic small molecule that reduces prostaglandin E2 (PGE2) biosynthesis and decreases markers of bone resorption. In animal models it increases femoral bone mineral density and lowers urinary calcium and collagen crosslinks. Supplied as a solid or as a pre-made DMSO solution for in vitro use.
- Orally active anti-osteoporotic agent with PGE2 inhibition.
- Reduces bone resorption markers such as pyridinoline and deoxypyridinoline.
- Demonstrated to increase femoral bone mineral density in animal models.
- High purity (98.1%) suitable for research applications.
- Soluble in DMSO (approx. 125 mg/mL) for in vitro testing.
- Available as solid and as prepared DMSO solution for convenience.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.